http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040047041-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e027020614a2f83d92564df41af9773 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6629ffa0b6250ec629e9f5f69a572f53 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-689 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y305-01025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-52 |
| filingDate | 2002-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa626ff7a03ace7ef024b6ae0243a06e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75487de6db61adac2cc30b819120cec2 |
| publicationDate | 2004-06-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20040047041-A |
| titleOfInvention | Industrial Applications and Genetic Information of Salbostatin and Trehalose biosynthesis related enzyme SalA, SalB, SalC, SalD, SalE, SalF, SalG, SalH, SalI, SalJ, SalK, SalL, SalM, SalN, SalO, SalP, SalQ |
| abstract | The present invention relates to the gene sequence and amino acid sequence of the enzyme for salbostatin biosynthesis and its industrial application, the acetylglucosamine phosphate deacetylase derived from Streptomyces albus KCTC9015 (N-acetylglucosamine -6-phosphate deacetylase Homologous Enzyme SalA, Sugar Phosphorylation Homogenase SalB, Trehalose-phosphate synthase SalC, Transporter SalD, Trehalose Phosphate Phosphate Enzyme (Trehalose) -6-phosphate phosphatase SalE, ADP-glucose synthase SalF, regulator enzyme SalG, glycosyltransferase SalH, trehalose phosphorylase SalI, reducte Reductase SalJ, Transporter Enzyme SalK, Bagioron Kinase (2-epi-5-epi-val iolone 7-kinase) SalL, Cyclitol dehydrogenase SalM, Cyclitol oxidoreductase SalN, Valorone-7-phosphate 2-epimerase SalO, Hydro Hydrolase SalP, 2-epi-5-epi-valiolone synthase SalQ has the effect of determining the gene sequence and amino acid sequence provided, while the bioactive substance containing the valienamine structure is mainly It has alpha-glucosidase inhibition effect, which is why it is an important compound that is being developed as an obesity drug and pesticide in agriculture. Therefore, enzymes that biosynthesize the valienamine structure, namely, 2-epi-5-epi-valiolone 7-kinase SalL, Cyclitol dehydrogenase SalM, and cyclitol oxidoreductase ( Cyclitol oxidoreductase) SalN, the gene bases of the Valorone-7-phosphate 2-epimerase SalO, the hydrolase SalP, the 2-epi-5-epi-valiolone synthase SalQ Since the sequence and amino acid sequence can be usefully applied to the production of primers and DNA chips for screening the bioactive substance producing strain having a valienamine structure, industrial effects can be expected. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100761340-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008100021-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010024493-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20080076193-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100752683-B1 |
| priorityDate | 2002-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.